Article

Getting a better handle on IOP control

Author(s):

The procedures may result in temporary pressure spikes later than expected.

Reviewed by Jed Lusthaus, MBBS, MPH, FRANZCO

An example of hemoglobin video imaging showing improved aqueous outflow 4 weeks after trabecular bypass surgery with iStent inject. An aqueous column becomes clearly visible postoperatively, and the black arrow demonstrates the direction of flow. (Image courtesy of Jed Lusthaus, MBBS, MPH, FRANZCO)

An example of hemoglobin video imaging showing improved aqueous outflow 4 weeks after trabecular bypass surgery with iStent inject. An aqueous column becomes clearly visible postoperatively, and the black arrow demonstrates the direction of flow. (Image courtesy of Jed Lusthaus, MBBS, MPH, FRANZCO)

Contrary to what one might expect, the highest IOP spikes can occur 1 week after implantation of the iStent device (Glaukos) viatrabecular bypass surgery, not on postoperative day 1.

In addition, investigators have found that hemoglobin video imaging (HVI) may enhance our understanding of IOP control and aqueous outflow after trabecular bypass surgery with implantation of iStent Inject, Jed Lusthaus, aglaucoma pecialist and clinical researcher at Sydney Eye Hospital and The University of Sydney, told Ophthalmology Times®.

The ocular response to trabecular bypass surgery can vary greatly, from unpredictable IOP reductions to sharp IOP elevations, anywhere between 1 day and 2 weeks postoperatively.

However, Lusthaus cautioned that sudden IOP spikes after trabecular bypass surgery can pose safety concerns, especially in cases of advanced glaucoma. On the other hand, such events allow surgeons to study the pathophysiologic response of the aqueous outflow system.

Cohort study of open-angle glaucoma patients

Lusthaus and his team conducted a study of the short-term IOP fluctuations in 105 consecutive eyes during the 4 weeks after surgery.

Twenty patients underwent HVI preoperatively to assess changes in aqueous outflow, and another 5 eyes underwent HVI after cataract extraction and intraocular lens implantation. One nasal vein and 1 temporal aqueous vein were the imaging targets for aqueous outflow analysis.

All patients were evaluated preoperatively, on postoperative day 1, and at postoperative weeks 1 and 4.

The results indicated that IOP peaked 1 week after stent implantation and stabilized by week 4 (P < 0.0001). Greater than 30% IOP elevations from baseline occurred in 13% of the patients.

The evaluation at week 1 showed that 46.7% of patients had more than a 30% IOP increase at week 1 compared with day 1.

The aqueous outflow, represented by aqueous column cross-sectional area, showed inconsistent responses on imaging of targeted veins after trabecular bypass surgery; however, the eyes with the lowest outflow preoperatively experienced an increase at week 4.

Three outflow patterns were observed: recovered and improved laminar flow, in which 2 of 10 eyes had an IOP spike; preoperative laminar flow with a reduced or lost aqueous column at weeks 1 and 4, in which 3 of 6 eyes had an IOP spike; and redirected flow into adjacent vessels at week 1, in which 3 of 4 eyes developed an IOP spike.

Based on these results, investigators recommended that the IOP be monitored more frequently after trabecular bypass surgery and that prophylaxis should be considered in patients with advanced glaucoma. In addition, they noted that eyes with very low preoperative aqueous column cross-sectional areas are likely to have significant blockage of the trabecular meshwork and may benefit from trabecular bypass surgery.

“Understanding the significance of different aqueous outflow responses to trabecular bypass surgery may advance our understanding of glaucoma pathophysiology and improve perioperative decision-making,” Lusthaus concluded.

Jed Lusthaus, MBBS, MPH, FRANZCO

E: jed.lusthaus@sydney.edu.au

The Sydney Eye Hospital Foundation, Glaukos Corporation, and Carl Zeiss Meditec provided equipment grants for this study.

Related Videos
Eye stroke: Mount Sinai program stresses awareness and emergent care for sudden vision loss
What the re:Vive 2.0 platform may mean for the future of vision diagnostics
Deep learning analysis detects diabetic retinopathy on ultra-widefield scanning laser ophthalmoscope images
© 2024 MJH Life Sciences

All rights reserved.